Drug General Information
Drug ID
D03SJA
Former ID
DCL000518
Drug Name
Dulanermin
Drug Type
Small molecular drug
Indication Indolent relapsed non-hodgkin's lymphoma; Metastatic non-small cell lung cancer; Metastatic colorectal cancer [ICD9: 140-229, 162, 200, 202, 202.8, 204.0, 153, 154; ICD10:C33, C33-C34, C34, C81-C86, C82-C85, C91.0, C18-C21] Terminated [550794]
Company
Genentech
Structure
Download
2D MOL

3D MOL

Formula
C13H12N2O5S
Canonical SMILES
CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2
InChI
1S/C13H12N2O5S/c1-21(18,19)14-12-8-7-10(15(16)17)9-13(12)20-11-5-3-2-4-6-11/h2-9,14H,1H3
InChIKey
HYWYRSMBCFDLJT-UHFFFAOYSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) TNF related apoptosis inducing ligand Target Info Modulator [556264]
KEGG Pathway Cytokine-cytokine receptor interaction
FoxO signaling pathway
Apoptosis
Natural killer cell mediated cytotoxicity
Measles
Influenza A
NetPath Pathway IL2 Signaling Pathway
IL4 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
TNFalpha Signaling Pathway
Leptin Signaling Pathway
PANTHER Pathway Apoptosis signaling pathway
Pathway Interaction Database TRAIL signaling pathway
Caspase Cascade in Apoptosis
Reactome Ligand-dependent caspase activation
Regulation by c-FLIP
RIPK1-mediated regulated necrosis
CASP8 activity is inhibited
Dimerization of procaspase-8
TRAIL signaling
WikiPathways Apoptosis
Extrinsic Pathway for Apoptosis
Apoptosis Modulation and Signaling
TP53 Network
References
Ref 550794Clinical pipeline report, company report or official report of Genentech (2011).
Ref 556264Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.